trenzyme’s managing director, Dr. Reinhold Horlacher, had the opportunity to speak at the PEGS Europe Virtual – Protein & Antibody Engineering Summit on November 11th (supported by our partner Polyplus-transfection®). After his presentation on “High-Yield Production of SARS-CoV-2 Proteins: From Small Scale Transfection to GMP Compliant Process”, he participated in the Livel Panel Discussion “Overcoming Expression and Production Challenges”. If you did not have the opportunity to listen to the presentation, you can watch the recording here and learn more about how trenzyme supports research groups in the development of serological tests, the generation of high-affinity antibodies and new vaccine candidates.